Gamida Cell Ltd., of Boston, said it priced its IPO of 6.25 million shares at $8 each, for aggregate gross proceeds of $50 million. The underwriters have been granted a 30-day option to purchase up to 937,500 additional shares at the initial offering price. The company's shares began trading on Nasdaq under the ticker symbol GMDA, closing Friday at $8.44.